Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis

Rheumatology International

Volumn 24, Issue 5, 2004, Pages 283-290

  Zurita Salinas, Camilo S ^a   Krötzsch, Edgar ^b   Díaz De León, Lino ^b   Alcocer Varela, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Collagen turnover; Disease duration; Fibroblasts; Systemic sclerosis

Indexed keywords

CARBON 14; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; PROLINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CELL CLONE; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; ZYMOGRAPHY;

ADULT; AGE OF ONSET; CARBON RADIOISOTOPES; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FIBROBLASTS; GELATINASES; HUMANS; MALE; MIDDLE AGED; PROLINE; SCLERODERMA, SYSTEMIC; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 4644305472     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0364-6     Document Type: Article

References (45)

1. Krieg T, Meurer M (1988) Systemic scleroderma, clinical and pathophysiological aspects. J Am Acad Dermatol 18:457-487
2. Perez M, Kohn S (1993) Systemic sclerosis. J Am Acad Dermatol 28:525-547
3. Black C (1993) The aetiopathogenesis of systemic sclerosis. J Int Med 243:3-8
4. Gay S, Trabandt A, Moreland LW, Gay RE (1992) Growth factors, extracellular matrix, and oncogenes in scleroderma. Arthritis Rheum 35:304-310
5. Bashey R, Millan A, Jiménez SA (1984) Increased biosynthesis of glycosaminoglycans by scleroderma fibroblasts in culture. Arthritis Rheum 27:1040-1045
6. Fleischmajer R, Perlish JS, Krieg T, Timpl R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400-403
7. Herrmann K, Heckmann M, Kulozik M, Haustein UF, Krieg T (1991) Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol 97:219-222
8. Buckingham RB, Prince RK, Rodnan G (1981) Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan. Clin Res 29:163-167
9. Kähäri V-M (1993) Activation of dermal connective tissue in scleroderma. Ann Med 25:511-518
10. Kähäri V-M, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6:199-213
11. Fields GB, Netzel-Arnett SJ, Windsor LJ, Engler JA, Birkedal-Hansen H, van Wart HE (1990) Proteolitic activities of human fibroblast collagenase: hydrolysis of a broad range of substrates at single active site. Biochemistry 29:6670-6677
12. Uitto J, Bauer EA, Eisen AZ (1979) Scleroderma. Increased bio-synthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase in skin fibroblasts in culture. J Clin Invest 64:921-930
13. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y (1994) Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 103:359-363
14. Bou-Gharios G, Osman J, Black C, Olsen I (1994) Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 231:69-78
15. Mignatti P (1995) Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney Int 47 [Suppl 49]:S12-S14
16. Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154
17. Murphy G, Willenbrock F (1995) Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol 248:496-510
18. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271:30375-30380
19. Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K (1995) Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 33:973-978
20. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. FEBS Lett 298:29-32
21. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
22. LeRoy EC, Krieg T, Black, C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15:202-205
23. Korn JH, Torres D, Downie E (1984) Clonal heterogeneity in the fibroblast response to mononuclear cell derived mediators. Arthritis Rheum 27:174-179
24. Jordana M, Schulman J, McSharry C, Irving LB, Newhouse M, Jordana G, Gauldie J (1988) Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 137:579-584
25. Diegelmann R, Graham M, Bryson G (1990) An in vitro microassay to quantitate collagen synthesis and its utility for analyzing the effects of defined inflammatory mediators. Ann NY Acad Sci 580:514-517
26. Diegelmann R, Peterkofsky B (1972) Inhibition of collagen secretion from bone and cultured fibroblast by microtubular disruptive drugs. Proc Nat Acad Sci U S A 69:892-896
27. Zurita-Salinas CS, Richaud-Patin Y, Krötzsch-Gómez E, Díaz de León L, Alcocer-Varela J, Palacios-Boix A (1998) Spontaneous cytokine gene expression by cultured skin fibroblasts of systemic sclerosis. Correlation with collagen synthesis. Rev Invest Clin 50:97-104
28. Labarca C, Paigen K (1980) A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352
29. Miller EJ, Rhodes RK (1982) Preparation and characterization of the different types of collagen. Methods Enzymol 82:33-64
30. Heussen C, Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing SDS and copolymerized substrates. Anal Biochem 102:196-202
31. Murphy G, Cockett MI, Ward RV, Docherty AJP (1991) Matrix metalloprotease degradation of elastin, type IV collagen and proteoglycan. Biochem J 277:277-279
32. LeRoy EC (1974) Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 54:880-889
33. Krieg T, Luderschmit C, Weber L, Müller PK, Braun-Falco O (1981) Scleroderma fibroblasts: some aspects of in vitro assessment of collagen synthesis. Arch Dermatol Res 270:263-272
34. Perlish IS, Bashey RI, Stephens RE, Fleischmajer R (1976) Connective tissue synthesis by cultured scleroderma fibroblasts. I. In vitro collagen synthesis by normal and scleroderma dermal fibroblasts. Arthritis Rheum 19:891-901
35. Murphy G, Willenbrock F, Crabbe T, O'Shea MO, Ward R, Atkinson S, O'Connel J, Docherty A (1994) Regulation of MMPase activity. In: Greenwald RA, Golub CM (eds) Inhibition of MMPs therapeutic potential. NY Acad Sci 732:31-41
36. Neely AN, Brown R, Clendening C, Orloff MM, Gardner J, Greenhalgh D (1997) Proteolytic activity in human burn wounds. Wound Rep Reg 5:302-309
37. Garcia R, Ballesteros LM, Hernández-Pérez O, Rosales AM, Espinosa R, Soto H, Díaz de León L, Rosado A (1997) Metalloproteinase activity during growth, maturation and atresia in the ovarian follicles of the goat. Anim Reprod Sci 47:211-228
38. Birkedal-Hansen H, Moore W, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engles JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250
39. Welgus HG, Bauer EA, Stricklin GP (1986) Elevated levels of human collagenase inhibitor in blister fluids of diverse etiology. J Invest Dermatol 87:592-596
40. Fries KM, Blieden T, Looney R, Sempowski G, Silvera M, Willis R, Phipps RP (1994) Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 72:283-292
41. Botstein GR, Sherer G, LeRoy EC (1982) Fibroblast selection in scleroderma. An alternative model of fibrosis. Arthritis Rheum 25:189-195
42. Needleman BW, Ordonez JV, Taramelli D, Alms W, Gayer K, Choi J (1990) In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients. Arthritis Rheum 33:842-852
43. Jelaska A, Arakawa M, Broketa G, Korn J (1996) Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum 39:1338-1346
44. Whiteside TL, Ferrarini M, Hebda P, Buckingham RB (1988) Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissues. Arthritis Rheum 31:1221-1229
45. Brinckerhoff CE, Nagel JE (1981) Collagenase production by cloned populations of rabbit synovial fibroblasts. Coll Relat Res 5:433-444